{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:21:07Z","timestamp":1747207267939,"version":"3.40.5"},"reference-count":107,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPPS"],"published-print":{"date-parts":[[2020,12,11]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>It has been well established that advanced glycation end-products (AGEs) have a strong\ncorrelation with diabetes and its secondary complications. Moreover, dicarbonyls, especially, methylglyoxal\n(MG) and glyoxal, accelerate AGEs formation and hence, have potential roles in the pathogenesis\nof diabetes. They can also induce oxidative stress and concomitantly decrease the efficiency of\nantioxidant enzymes. Increased proinflammatory cytokines (tumor necrosis factor-\u03b1 and interleukin-\n1\u03b2) are secreted by monocytes due to the dicarbonyl-modified proteins. High levels of blood dicarbonyls\nhave been identified in diabetes and its associated complications (retinopathy, nephropathy and\nneuropathy). This review aims to provide a better understanding by including in-depth information\nabout the formation of MG and glyoxal through multiple pathways with a focus on their biological\nfunctions and detoxifications. The potential role of these dicarbonyls in secondary diabetic complications\nis also discussed.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389203720666191010155145","type":"journal-article","created":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T12:46:01Z","timestamp":1572353161000},"page":"890-898","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Dicarbonyls Generation, Toxicities, Detoxifications and Potential Roles in Diabetes Complications"],"prefix":"10.2174","volume":"21","author":[{"given":"Sultan","family":"Alouffi","sequence":"first","affiliation":[{"name":"Molecular Diagnostic and Personalised Therapeutics Unit, University of Hail, Hail, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9089-9176","authenticated-orcid":true,"given":"Mohd Wajid Ali","family":"Khan","sequence":"additional","affiliation":[{"name":"Molecular Diagnostic and Personalised Therapeutics Unit, University of Hail, Hail, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"World Health Organization 2016. Global report on diabetes. World Health Organization."},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000312639","volume":"153","author":"Khan M.W.A.","year":"2010","unstructured":"Khan M.W.A.; Qadrie Z.L.; Khan W.A.; Antibodies against gluco-oxidatively modified human serum albumin detected in diabetes-associated complications. Int Arch Allergy Immunol 2010,153(2),207-214","journal-title":"Int Arch Allergy Immunol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2174\/1570161115666170327162639","volume":"15","author":"Ahmad S.","year":"2017","unstructured":"Ahmad S.; Siddiqui Z.; Rehman S.; Khan M.Y.; Khan H.; Khanum S.; Alouffi S.; Saeed M.; A glycation angle to look into the diabetic vasculopathy: Cause and cure. Curr Vasc Pharmacol 2017,15(4),352-364","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1042\/CS20160025","volume":"130","author":"Rabbani N.","year":"2016","unstructured":"Rabbani N.; Xue M.; Thornalley P.J.; Methylglyoxal-induced dicarbonyl stress in aging and disease: first steps towards glyoxalase 1-based treatments. Clin Sci (Lond) 2016,130(19),1677-1696","journal-title":"Clin Sci (Lond)"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.2337\/dc15-2727","volume":"39","author":"Welsh K.J.","year":"2016","unstructured":"Welsh K.J.; Kirkman M.S.; Sacks D.B.; Sacks D.B.; Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions. Diabetes Care 2016,39(8),1299-1306","journal-title":"Diabetes Care"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/jms.842","volume":"40","author":"Lapolla A.","year":"2005","unstructured":"Lapolla A.; Fedele D.; Reitano R.; Bonfante L.; Guizzo M.; Seraglia R.; Tubaro M.; Traldi P.; Mass spectrometric study of in vivo production of advanced glycation end-products\/peptides. J Mass Spectrom 2005,40(7),969-972","journal-title":"J Mass Spectrom"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/mas.20090","volume":"25","author":"Lapolla A.","year":"2006","unstructured":"Lapolla A.; Fedele D.; Seraglia R.; Traldi P.; The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update. Mass Spectrom Rev 2006,25(5),775-797","journal-title":"Mass Spectrom Rev"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1021\/pr800858h","volume":"8","author":"Zhang Q.","year":"2009","unstructured":"Zhang Q.; Ames J.M.; Smith R.D.; Baynes J.W.; Metz T.O.; A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. J Proteome Res 2009,8(2),754-769","journal-title":"J Proteome Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0009-8981(75)90007-8","volume":"59","author":"Wadman S.K.","year":"1975","unstructured":"Wadman S.K.; De Bree P.K.; Van Sprang F.J.; Kamerling J.P.; Haverkamp J.; Vliegenthart J.F.G.N.; -(Carboxymethyl)Lysine, A Constituent of Human Urine. Clin Chim Acta 1975,59(3),313-320","journal-title":"Clin Chim Acta"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1016\/S0021-9258(19)89188-3","volume":"261","author":"Ahmed M.U.","year":"1986","unstructured":"Ahmed M.U.; Thorpe S.R.; Baynes J.W.; Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 1986,261(11),4889-4894","journal-title":"J Biol Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0531-5131(02)00881-6","volume":"1245","author":"Thorpe S.R.","year":"2002","unstructured":"Thorpe S.R.; Baynes J.W.; CML: A Brief History. Int Congr Ser 2002,1245,91-99","journal-title":"Int Congr Ser"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"10964","DOI":"10.1021\/bi00501a014","volume":"29","author":"Dunn J.A.","year":"1990","unstructured":"Dunn J.A.; Ahmed M.U.; Murtiashaw M.H.; Richardson J.M.; Walla M.D.; Thorpe S.R.; Baynes J.W.; Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N epsilon-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate. Biochemistry 1990,29(49),10964-10970","journal-title":"Biochemistry"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"9982","DOI":"10.1074\/jbc.271.17.9982","volume":"271","author":"Fu M.X.","year":"1996","unstructured":"Fu M.X.; Requena J.R.; Jenkins A.J.; Lyons T.J.; Baynes J.W.; Thorpe S.R.; The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996,271(17),9982-9986","journal-title":"J Biol Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"12310","DOI":"10.1074\/jbc.M500733200","volume":"280","author":"Sell D.R.","year":"2005","unstructured":"Sell D.R.; Biemel K.M.; Reihl O.; Lederer M.O.; Strauch C.M.; Monnier V.M.; Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes. J Biol Chem 2005,280(13),12310-12315","journal-title":"J Biol Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.phrs.2012.03.004","volume":"65","author":"Sena C.M.","year":"2012","unstructured":"Sena C.M.; Matafome P.; Cris\u00f3stomo J.; Rodrigues L.; Fernandes R.; Pereira P.; Sei\u00e7a R.M.; Methylglyoxal promotes oxidative stress and endothelial dysfunction. Pharmacol Res 2012,65(5),497-506","journal-title":"Pharmacol Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1042\/bj3440109","volume":"344","author":"Thornalley P.J.","year":"1999","unstructured":"Thornalley P.J.; Langborg A.; Minhas H.S.; Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 1999,344(Pt 1),109-116","journal-title":"Biochem J"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"10017","DOI":"10.1074\/jbc.270.17.10017","volume":"270","author":"Glomb M.A.","year":"1995","unstructured":"Glomb M.A.; Monnier V.M.; Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 1995,270(17),10017-10026","journal-title":"J Biol Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","volume":"114","author":"Goldin A.","year":"2006","unstructured":"Goldin A.; Beckman J.A.; Schmidt A.M.; Creager M.A.; Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006,114(6),597-605","journal-title":"Circulation"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/oxfordjournals.jbchem.a002889","volume":"129","author":"Thornalley P.J.","year":"2001","unstructured":"Thornalley P.J.; Jahan I.; Ng R.; Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. J Biochem 2001,129(4),543-549","journal-title":"J Biochem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s12020-012-9795-8","volume":"43","author":"Matafome P.","year":"2013","unstructured":"Matafome P.; Sena C.; Sei\u00e7a R.; Methylglyoxal, obesity, and diabetes. Endocrine 2013,43(3),472-484","journal-title":"Endocrine"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00726-010-0783-0","volume":"42","author":"Rabbani N.","year":"2012","unstructured":"Rabbani N.; Thornalley P.J.; Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome. Amino Acids 2012,42(4),1133-1142","journal-title":"Amino Acids"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1042\/bj20030763","volume":"375","author":"Thornalley P.J.","year":"2003","unstructured":"Thornalley P.J.; Battah S.; Ahmed N.; Karachalias N.; Agalou S.; Babaei-Jadidi R.; Dawnay A.; Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 2003,375(Pt 3),581-592","journal-title":"Biochem J"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1167\/iovs.03-0573","volume":"44","author":"Ahmed N.","year":"2003","unstructured":"Ahmed N.; Thornalley P.J.; Dawczynski J.; Franke S.; Strobel J.; Stein G.; Haik G.M.; Methylglyoxal-derived hydroimidazolone advanced glycation end-products of human lens proteins. Invest Ophthalmol Vis Sci 2003,44(12),5287-5292","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1196\/annals.1333.031","volume":"1043","author":"Ahmed N.","year":"2005","unstructured":"Ahmed N.; Thornalley P.J.; Peptide mapping of human serum albumin modified minimally by methylglyoxal in vitro and in vivo. Ann N Y Acad Sci 2005,1043,260-266","journal-title":"Ann N Y Acad Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1042\/bj3490813","volume":"349","author":"Watanabe H.","year":"2000","unstructured":"Watanabe H.; Tanase S.; Nakajou K.; Maruyama T.; Kragh-Hansen U.; Otagiri M.; Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity. Biochem J 2000,349(Pt 3),813-819","journal-title":"Biochem J"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1262-3636(07)70183-0","volume":"31","author":"Faure P.","year":"2005","unstructured":"Faure P.; Troncy L.; Lecomte M.; Wiernsperger N.; Lagarde M.; Ruggiero D.; Halimi S.; Albumin antioxidant capacity is modified by methylglyoxal. Diabetes Metab 2005,31(2),169-177","journal-title":"Diabetes Metab"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"15654","DOI":"10.1021\/bi061410o","volume":"45","author":"Gao Y.","year":"2006","unstructured":"Gao Y.; Wang Y.; Site-selective modifications of arginine residues in human hemoglobin induced by methylglyoxal. Biochemistry 2006,45(51),15654-15660","journal-title":"Biochemistry"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1096\/fj.06-7536com","volume":"21","author":"Cantero A.V.","year":"2007","unstructured":"Cantero A.V.; Portero-Ot\u00edn M.; Ayala V.; Auge N.; Sanson M.; Elbaz M.; Thiers J.C.; Pamplona R.; Salvayre R.; N\u00e8gre-Salvayre A.; Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-beta: implications for diabetic atherosclerosis. FASEB J 2007,21(12),3096-3106","journal-title":"FASEB J"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1096\/fj.05-5478fje","volume":"20","author":"Jia X.","year":"2006","unstructured":"Jia X.; Olson D.J.; Ross A.R.; Wu L.; Structural and functional changes in human insulin induced by methylglyoxal. FASEB J 2006,20(9),1555-1557","journal-title":"FASEB J"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1042\/BJ20071006","volume":"409","author":"Biswas A.","year":"2008","unstructured":"Biswas A.; Wang B.; Miyagi M.; Nagaraj R.H.; Effect of methylglyoxal modification on stress-induced aggregation of client proteins and their chaperoning by human alphaA-crystallin. Biochem J 2008,409(3),771-777","journal-title":"Biochem J"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"Brownlee M.","year":"2001","unstructured":"Brownlee M.; Biochemistry and molecular cell biology of diabetic complications. Nature 2001,414(6865),813-820","journal-title":"Nature"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.fct.2013.06.052","volume":"60","author":"Poulsen M.W.","year":"2013","unstructured":"Poulsen M.W.; Hedegaard R.V.; Andersen J.M.; de Courten B.; B\u00fcgel S.; Nielsen J.; Skibsted L.H.; Dragsted L.O.; Advanced glycation endproducts in food and their effects on health. Food Chem Toxicol 2013,60,10-37","journal-title":"Food Chem Toxicol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0165-2478(97)00080-1","volume":"58","author":"Abordo E.A.","year":"1997","unstructured":"Abordo E.A.; Thornalley P.J.; Synthesis and secretion of tumour necrosis factor-alpha by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts. Immunol Lett 1997,58(3),139-147","journal-title":"Immunol Lett"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"32293","DOI":"10.1016\/S0021-9258(18)31634-X","volume":"269","author":"Westwood M.E.","year":"1994","unstructured":"Westwood M.E.; McLellan A.C.; Thornalley P.J.; Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. Competition with advanced glycation end product-modified serum albumin at the advanced glycation end product receptor. J Biol Chem 1994,269(51),32293-32298","journal-title":"J Biol Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0003-9861(02)00599-4","volume":"409","author":"Fan X.","year":"2003","unstructured":"Fan X.; Subramaniam R.; Weiss M.F.; Monnier V.M.; Methylglyoxal-bovine serum albumin stimulates tumor necrosis factor alpha secretion in RAW 264.7 cells through activation of mitogen-activating protein kinase, nuclear factor kappaB and intracellular reactive oxygen species formation. Arch Biochem Biophys 2003,409(2),274-286","journal-title":"Arch Biochem Biophys"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0165-2478(96)02496-0","volume":"50","author":"Westwood M.E.","year":"1996","unstructured":"Westwood M.E.; Thornalley P.J.; Induction of synthesis and secretion of interleukin 1 beta in the human monocytic THP-1 cells by human serum albumins modified with methylglyoxal and advanced glycation endproducts. Immunol Lett 1996,50(1-2),17-21","journal-title":"Immunol Lett"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0167-4889(96)00154-1","volume":"1356","author":"Westwood M.E.","year":"1997","unstructured":"Westwood M.E.; Argirov O.K.; Abordo E.A.; Thornalley P.J.; Methylglyoxal-modified arginine residues--a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells. Biochim Biophys Acta 1997,1356(1),84-94","journal-title":"Biochim Biophys Acta"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jdiacomp.2012.10.004","volume":"27","author":"Monnier V.M.","year":"2013","unstructured":"Monnier V.M.; Sell D.R.; Strauch C.; Sun W.; Lachin J.M.; Cleary P.A.; Genuth S.; The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes. J Diabetes Complications DCCT Research Group2013,27(2),141-149","journal-title":"J Diabetes Complications"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.abb.2012.12.001","volume":"529","author":"Bose T.","year":"2013","unstructured":"Bose T.; Bhattacherjee A.; Banerjee S.; Chakraborti A.S.; Methylglyoxal-induced modifications of hemoglobin: structural and functional characteristics. Arch Biochem Biophys 2013,529(2),99-104","journal-title":"Arch Biochem Biophys"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3390\/ijms18050984","volume":"18","author":"Brings S.","year":"2017","unstructured":"Brings S.; Fleming T.; Freichel M.; Muckenthaler M.U.; Herzig S.; Nawroth P.P.; Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention. Int J Mol Sci 2017,18(5),984","journal-title":"Int J Mol Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.2337\/db05-1634","volume":"55","author":"Dobler D.","year":"2006","unstructured":"Dobler D.; Ahmed N.; Song L.; Eboigbodin K.E.; Thornalley P.J.; Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes 2006,55(7),1961-1969","journal-title":"Diabetes"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1474-9726.2008.00371.x","volume":"7","author":"Morcos M.","year":"2008","unstructured":"Morcos M.; Du X.; Pfisterer F.; Hutter H.; Sayed A.A.; Thornalley P.; Ahmed N.; Baynes J.; Thorpe S.; Kukudov G.; Schlotterer A.; Bozorgmehr F.; El Baki R.A.; Stern D.; Moehrlen F.; Ibrahim Y.; Oikonomou D.; Hamann A.; Becker C.; Zeier M.; Schwenger V.; Miftari N.; Humpert P.; Hammes H.P.; Buechler M.; Bierhaus A.; Brownlee M.; Nawroth P.P.; Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell 2008,7(2),260-269","journal-title":"Aging Cell"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"670","DOI":"10.2337\/db08-1565","volume":"59","author":"Queisser M.A.","year":"2010","unstructured":"Queisser M.A.; Yao D.; Geisler S.; Hammes H.P.; Lochnit G.; Schleicher E.D.; Brownlee M.; Preissner K.T.; Hyperglycemia impairs proteasome function by methylglyoxal. Diabetes 2010,59(3),670-678","journal-title":"Diabetes"},{"key":"ref=44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030257","volume":"7","author":"Nagaraj R.H.","year":"2012","unstructured":"Nagaraj R.H.; Panda A.K.; Shanthakumar S.; Santhoshkumar P.; Pasupuleti N.; Wang B.; Biswas A.; Hydroimidazolone modification of the conserved Arg12 in small heat shock proteins: studies on the structure and chaperone function using mutant mimics. PLoS One 2012,7(1)","journal-title":"PLoS One"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1089\/ars.2009.2484","volume":"11","author":"Negre-Salvayre A.","year":"2009","unstructured":"Negre-Salvayre A.; Salvayre R.; Aug\u00e9 N.; Pamplona R.; Portero-Ot\u00edn M.; Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal 2009,11(12),3071-3109","journal-title":"Antioxid Redox Signal"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.semcdb.2011.02.013","volume":"22","author":"Xue M.","year":"2011","unstructured":"Xue M.; Rabbani N.; Thornalley P.J.; Glyoxalase in ageing. Semin Cell Dev Biol 2011,22(3),293-301","journal-title":"Semin Cell Dev Biol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.semcdb.2011.02.006","volume":"22","author":"Thornalley P.J.","year":"2011","unstructured":"Thornalley P.J.; Rabbani N.; Glyoxalase in tumourigenesis and multidrug resistance. Semin Cell Dev Biol 2011,22(3),318-325","journal-title":"Semin Cell Dev Biol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1534\/g3.111.000505","volume":"1","author":"Hoon S.","year":"2011","unstructured":"Hoon S.; Gebbia M.; Costanzo M.; Davis R.W.; Giaever G.; Nislow C.; A global perspective of the genetic basis for carbonyl stress resistance. G3 (Bethesda) 2011,1(3),219-231","journal-title":"G3 (Bethesda)"},{"key":"ref=49","first-page":"502","volume":"49","author":"Neuberg C.","year":"1913","unstructured":"Neuberg C.; The destruction of lactic aldehyde and methylglyoxal by animal organs. Biochem Z 1913,49,502-506","journal-title":"Biochem Z"},{"key":"ref=50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010399","volume":"5","author":"Birkenmeier G.","year":"2010","unstructured":"Birkenmeier G.; Stegemann C.; Hoffmann R.; G\u00fcnther R.; Huse K.; Birkemeyer C.; Posttranslational modification of human glyoxalase 1 indicates redox-dependent regulation. PLoS One 2010,5(4)","journal-title":"PLoS One"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1042\/bj3440837","volume":"344","author":"Mitsumoto A.","year":"1999","unstructured":"Mitsumoto A.; Kim K.R.; Oshima G.; Kunimoto M.; Okawa K.; Iwamatsu A.; Nakagawa Y.; Glyoxalase I is a novel nitric-oxide-responsive protein. Biochem J 1999,344(Pt 3),837-844","journal-title":"Biochem J"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11010-009-0031-7","volume":"325","author":"de Hemptinne V.","year":"2009","unstructured":"de Hemptinne V.; Rondas D.; Toepoel M.; Vancompernolle K.; Phosphorylation on Thr-106 and NO-modification of glyoxalase I suppress the TNF-induced transcriptional activity of NF-kappaB. Mol Cell Biochem 2009,325(1-2),169-178","journal-title":"Mol Cell Biochem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00125-011-2393-0","volume":"55","author":"Berner A.K.","year":"2012","unstructured":"Berner A.K.; Brouwers O.; Pringle R.; Klaassen I.; Colhoun L.; McVicar C.; Brockbank S.; Curry J.W.; Miyata T.; Brownlee M.; Schlingemann R.O.; Schalkwijk C.; Stitt A.W.; Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology. Diabetologia 2012,55(3),845-854","journal-title":"Diabetologia"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-4419-1241-1_6","volume":"662","author":"Inagi R.","year":"2010","unstructured":"Inagi R.; Kumagai T.; Fujita T.; Nangaku M.; The role of glyoxalase system in renal hypoxia. Adv Exp Med Biol 2010,662,49-55","journal-title":"Adv Exp Med Biol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.expneurol.2011.12.015","volume":"234","author":"Jack M.M.","year":"2012","unstructured":"Jack M.M.; Ryals J.M.; Wright D.E.; Protection from diabetes-induced peripheral sensory neuropathy--a role for elevated glyoxalase I? Exp Neurol 2012,234(1),62-69","journal-title":"Exp Neurol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1365-2052.1984.tb01099.x","volume":"15","author":"Agar N.S.","year":"1984","unstructured":"Agar N.S.; Board P.G.; Bell K.; Studies of erythrocyte glyoxalase II in various domestic species: discovery of glyoxalase II deficiency in the horse. Anim Blood Groups Biochem Genet 1984,15(1),67-70","journal-title":"Anim Blood Groups Biochem Genet"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20121743","volume":"453","author":"Sousa Silva M.","year":"2013","unstructured":"Sousa Silva M.; Gomes R.A.; Ferreira A.E.; Ponces Freire A.; Cordeiro C.; The glyoxalase pathway: the first hundred years and beyond. Biochem J 2013,453(1),1-15","journal-title":"Biochem J"},{"key":"ref=58","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/819202","volume":"2012","author":"Lange J.N.","year":"2012","unstructured":"Lange J.N.; Wood K.D.; Knight J.; Assimos D.G.; Holmes R.P.; Glyoxal formation and its role in endogenous oxalate synthesis. Adv Urol 2012,2012","journal-title":"Adv Urol"},{"key":"ref=59","first-page":"9","volume":"685204","author":"Nikiforova V.J.","year":"2014","unstructured":"Nikiforova V.J.; Giesbertz P.; Wiemer J.; Bethan B.; Looser R.; Liebenberg V.; Noppinger P.R.; Daniel H.; Rein D.; Glyoxylate, a New Marker Metabolite of Type 2 Diabetes 2014,685204,9"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1021\/bi00011a027","volume":"34","author":"Wells-Knecht K.J.","year":"1995","unstructured":"Wells-Knecht K.J.; Zyzak D.V.; Litchfield J.E.; Thorpe S.R.; Baynes J.W.; Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 1995,34(11),3702-3709","journal-title":"Biochemistry"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1021\/tx0155092","volume":"14","author":"Awada M.","year":"2001","unstructured":"Awada M.; Dedon P.C.; Formation of the 1,N2-glyoxal adduct of deoxyguanosine by phosphoglycolaldehyde, a product of 3\u2032-deoxyribose oxidation in DNA. Chem Res Toxicol 2001,14(9),1247-1253","journal-title":"Chem Res Toxicol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/10408440591002183","volume":"35","author":"O\u2019Brien P.J.","year":"2005","unstructured":"O\u2019Brien P.J.; Siraki A.G.; Shangari N.; Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit Rev Toxicol 2005,35(7),609-662","journal-title":"Crit Rev Toxicol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"25741","DOI":"10.1074\/jbc.273.40.25741","volume":"273","author":"Benov L.","year":"1998","unstructured":"Benov L.; Fridovich I.; Superoxide dependence of the toxicity of short chain sugars. J Biol Chem 1998,273(40),25741-25744","journal-title":"J Biol Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1021\/jf980626x","volume":"47","author":"Hofmann T.","year":"1999","unstructured":"Hofmann T.; Bors W.; Stettmaier K.; Studies on radical intermediates in the early stage of the nonenzymatic browning reaction of carbohydrates and amino acids. J Agric Food Chem 1999,47(2),379-390","journal-title":"J Agric Food Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0005-2760(94)90264-X","volume":"1211","author":"Loidl-Stahlhofen A.","year":"1994","unstructured":"Loidl-Stahlhofen A.; Spiteller G.; \u03b1-Hydroxyaldehydes, products of lipid peroxidation. Biochim Biophys Acta 1994,1211(2),156-160","journal-title":"Biochim Biophys Acta"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0005-2760(94)90046-9","volume":"1214","author":"Mlakar A.","year":"1994","unstructured":"Mlakar A.; Spiteller G.; Reinvestigation of lipid peroxidation of linolenic acid. Biochim Biophys Acta 1994,1214(2),209-220","journal-title":"Biochim Biophys Acta"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0009-3084(96)02557-1","volume":"82","author":"Dudda A.","year":"1996","unstructured":"Dudda A.; Spiteller G.; Kobelt F.; Lipid oxidation products in ischemic porcine heart tissue. Chem Phys Lipids 1996,82(1),39-51","journal-title":"Chem Phys Lipids"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/carcin\/16.9.2251","volume":"16","author":"Murata-Kamiya N.","year":"1995","unstructured":"Murata-Kamiya N.; Kamiya H.; Iwamoto N.; Kasai H.; Formation of a mutagen, glyoxal, from DNA treated with oxygen free radicals. Carcinogenesis 1995,16(9),2251-2253","journal-title":"Carcinogenesis"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/nar\/25.10.1897","volume":"25","author":"Murata-Kamiya N.","year":"1997","unstructured":"Murata-Kamiya N.; Kamiya H.; Kaji H.; Kasai H.; Glyoxal, a major product of DNA oxidation, induces mutations at G:C sites on a shuttle vector plasmid replicated in mammalian cells. Nucleic Acids Res 1997,25(10),1897-1902","journal-title":"Nucleic Acids Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0531-5131(02)00879-8","volume":"1245","author":"Agalou S.","year":"2002","unstructured":"Agalou S.; Karachalias N.; Thornalley P.J.; Tucker B.; Dawnay A.B.; Estimation of \u03b1-oxoaldehydes formed from the degradation of glycolytic intermediates and glucose fragmentation in blood plasma of human subjects with uraemia. Excerpta Medica International Congress Series, 2002,1245,181-182","journal-title":"Excerpta Medica International Congress Series,"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/rcm.992","volume":"17","author":"Lapolla A.","year":"2003","unstructured":"Lapolla A.; Flamini R.; Tonus T.; Fedele D.; Senesi A.; Reitano R.; Marotta E.; Pace G.; Seraglia R.; Traldi P.; An effective derivatization method for quantitative determination of glyoxal and methylglyoxal in plasma samples by gas chromatography\/mass spectrometry. Rapid Commun Mass Spectrom 2003,17(8),876-878","journal-title":"Rapid Commun Mass Spectrom"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.bcp.2004.06.013","volume":"68","author":"Shangari N.","year":"2004","unstructured":"Shangari N.; O\u2019Brien P.J.; The cytotoxic mechanism of glyoxal involves oxidative stress. Biochem Pharmacol 2004,68(7),1433-1442","journal-title":"Biochem Pharmacol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0006-2952(99)00132-X","volume":"58","author":"Abordo E.A.","year":"1999","unstructured":"Abordo E.A.; Minhas H.S.; Thornalley P.J.; Accumulation of \u03b1-oxoaldehydes during oxidative stress: a role in cytotoxicity. Biochem Pharmacol 1999,58(4),641-648","journal-title":"Biochem Pharmacol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1046\/j.1523-1755.2001.00051.x","volume":"60","author":"Miyata T.","year":"2001","unstructured":"Miyata T.; van Ypersele de Strihou C.; Imasawa T.; Yoshino A.; Ueda Y.; Ogura H.; Kominami K.; Onogi H.; Inagi R.; Nangaku M.; Kurokawa K.; Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient. Kidney Int 2001,60(6),2351-2359","journal-title":"Kidney Int"},{"key":"ref=75","first-page":"99","volume":"20","author":"Thornalley P.J.","year":"1995","unstructured":"Thornalley P.J.; Advances in glyoxalase research.Glyoxalase expression in malignancy, anti-proliferative effects of methylglyoxal, glyoxalase I inhibitor diesters and S-D-lactoylglutathione, and methylglyoxal-modified protein binding and endocytosis by advanced glycation endproduct receptor. Critical Reviews in Oncology\/ Hematology. 1995,20(1-1),99-128"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0009-2797(97)00157-9","volume":"111-112","author":"Thornalley P.J.","year":"1998","unstructured":"Thornalley P.J.; Glutathione-dependent detoxification of \u03b1-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors. Chem Biol Interact 1998,111-112,137-151","journal-title":"Chem Biol Interact"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","volume":"26","author":"Fowler M.J.","year":"2008","unstructured":"Fowler M.J.; Microvascular and Macrovascular Complications of Diabetes. Clin Diabetes 2008,26(2),77-82","journal-title":"Clin Diabetes"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000312639","volume":"153","author":"Khan M.W.A.","year":"2010","unstructured":"Khan M.W.A.; Qadrie Z.L.; Khan W.A.; Antibodies against gluco-oxidative modified HSA-detected in diabetes associated complications. Int Arch Allergy Immunol 2010,153,207-214","journal-title":"Int Arch Allergy Immunol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000489896","volume":"177","author":"Alouffi S.","year":"2018","unstructured":"Alouffi S.; Sherwani S.; Al-Mogbel M.S.; Sherwani M.K.A.; Ali Khan M.W.; Depression and smoking augment the production of circulating autoantibodies against glycated-HSA in rheumatoid arthritis patients. Int Arch Allergy Immunol 2018,177(2),170-180","journal-title":"Int Arch Allergy Immunol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"Brownlee M.","year":"2001","unstructured":"Brownlee M.; Biochemistry and molecular cell biology of diabetic complications. Nature 2001,414(6865),813-820","journal-title":"Nature"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1515\/cclm-2012-0818","volume":"52","author":"Voziyan P.","year":"2014","unstructured":"Voziyan P.; Brown K.L.; Chetyrkin S.; Hudson B.; Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes. Clin Chem Lab Med 2014,52(1),39-45","journal-title":"Clin Chem Lab Med"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.2337\/db16-1578","volume":"66","author":"Hanssen N.M.J.","year":"2017","unstructured":"Hanssen N.M.J.; Scheijen J.L.J.M.; Jorsal A.; Parving H.H.; Tarnow L.; Rossing P.; Stehouwer C.D.A.; Schalkwijk C.G.; Higher plasma methylglyoxal levels are associated with incident cardiovascular disease in individuals with type 1 diabetes: A 12-Year Follow-up Study. Diabetes 2017,66(8),2278-2283","journal-title":"Diabetes"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.2337\/dc18-0159","volume":"41","author":"Hanssen N.M.J.","year":"2018","unstructured":"Hanssen N.M.J.; Westerink J.; Scheijen J.L.J.M.; van der Graaf Y.; Stehouwer C.D.A.; Schalkwijk C.G.; Higher plasma methylglyoxal levels are associated with incident cardiovascular disease and mortality in individuals with type 2 diabetes. Diabetes Care SMART Study Group2018,41(8),1689-1695","journal-title":"Diabetes Care"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.diabres.2012.11.003","volume":"99","author":"Kalapos M.P.","year":"2013","unstructured":"Kalapos M.P.; Where does plasma methylglyoxal originate from? Diabetes Res Clin Pract 2013,99(3),260-271","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3390\/ijms18050984","volume":"18","author":"Brings S.","year":"2017","unstructured":"Brings S.; Fleming T.; Freichel M.; Muckenthaler M.U.; Herzig S.; Nawroth P.P.; Dicarbonyls and advanced glycation end-products in the development of diabetic complications and targets for intervention. Int J Mol Sci 2017,18(5),984","journal-title":"Int J Mol Sci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.diabres.2019.01.002","volume":"148","author":"Bellier J.","year":"2019","unstructured":"Bellier J.; Nokin M.J.; Lard\u00e9 E.; Karoyan P.; Peulen O.; Castronovo V.; Bellahc\u00e8ne A.; Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer. Diabetes Res Clin Pract 2019,148,200-211","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"Forbes J.M.","year":"2013","unstructured":"Forbes J.M.; Cooper M.E.; Mechanisms of diabetic complications. Physiol Rev 2013,93(1),137-188","journal-title":"Physiol Rev"},{"key":"ref=88","first-page":"5","volume":"8","author":"Tezuka Y.","year":"2018","unstructured":"Tezuka Y.; Nakaya I.; Nakayama K.; Nakayama M.; Yahata M.; Soma J.; Methylglyoxal as a prognostic factor in patients with chronic kidney disease. Nephrology (Carlton) 2018,8,5","journal-title":"Nephrology (Carlton)"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ijbiomac.2018.04.016","volume":"115","author":"Khan M.Y.","year":"2018","unstructured":"Khan M.Y.; Alouffi S.; Ahmad S.; Immunochemical studies on native and glycated LDL - An approach to uncover the structural perturbations. Int J Biol Macromol 2018,115,287-299","journal-title":"Int J Biol Macromol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/MNH.0000000000000465","volume":"28","author":"Hanssen N.M.J.","year":"2019","unstructured":"Hanssen N.M.J.; Stehouwer C.D.A.; Schalkwijk C.G.; Methylglyoxal stress, the glyoxalase system, and diabetic chronic kidney disease. Curr Opin Nephrol Hypertens 2019,28(1),26-33","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1111\/dme.13201","volume":"33","author":"Jensen T.M.","year":"2016","unstructured":"Jensen T.M.; Vistisen D.; Fleming T.; Nawroth P.P.; Rossing P.; J\u00f8rgensen M.E.; Lauritzen T.; Sandbaek A.; Witte D.R.; Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus. Diabet Med 2016,33(12),1625-1631","journal-title":"Diabet Med"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.2337\/dc12-2689","volume":"36","author":"Beisswenger P.J.","year":"2013","unstructured":"Beisswenger P.J.; Howell S.K.; Russell G.B.; Miller M.E.; Rich S.S.; Mauer M.; Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products. Diabetes Care 2013,36(10),3234-3239","journal-title":"Diabetes Care"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/nm.2750","volume":"18","author":"Bierhaus A.","year":"2012","unstructured":"Bierhaus A.; Fleming T.; Stoyanov S.; Leffler A.; Babes A.; Neacsu C.; Sauer S.K.; Eberhardt M.; Schn\u00f6lzer M.; Lasitschka F.; Neuhuber W.L.; Kichko T.I.; Konrade I.; Elvert R.; Mier W.; Pirags V.; Lukic I.K.; Morcos M.; Dehmer T.; Rabbani N.; Thornalley P.J.; Edelstein D.; Nau C.; Forbes J.; Humpert P.M.; Schwaninger M.; Ziegler D.; Stern D.M.; Cooper M.E.; Haberkorn U.; Brownlee M.; Reeh P.W.; Nawroth P.P.; Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat Med 2012,18(6),926-933","journal-title":"Nat Med"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1042\/CS20140683","volume":"128","author":"Maessen D.E.M.","year":"2015","unstructured":"Maessen D.E.M.; Stehouwer C.D.A.; Schalkwijk C.G.; The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases. Clin Sci (Lond) 2015,128(12),839-861","journal-title":"Clin Sci (Lond)"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.yexcr.2011.10.013","volume":"318","author":"Kim K.M.","year":"2012","unstructured":"Kim K.M.; Kim Y.S.; Jung D.H.; Lee J.; Kim J.S.; Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose. Exp Cell Res 2012,318(2),152-159","journal-title":"Exp Cell Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jns.2012.05.030","volume":"322","author":"Federico A.","year":"2012","unstructured":"Federico A.; Cardaioli E.; Da Pozzo P.; Formichi P.; Gallus G.N.; Radi E.; Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci 2012,322(1-2),254-262","journal-title":"J Neurol Sci"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1016\/j.cub.2016.09.024","volume":"26","author":"Chaudhuri J.","year":"2016","unstructured":"Chaudhuri J.; Bose N.; Gong J.; Hall D.; Rifkind A.; Bhaumik D.; Peiris T.H.; Chamoli M.; Le C.H.; Liu J.; Lithgow G.J.; Ramanathan A.; Xu X.Z.S.; Kapahi P.; A Caenorhabditis elegans model elucidates a conserved role for TRPA1-Nrf signaling in reactive \u00ce\u00b1-dicarbonyl detoxification. Curr Biol 2016,26(22),3014-3025","journal-title":"Curr Biol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.cmet.2018.02.003","volume":"27","author":"Moraru A.","year":"2018","unstructured":"Moraru A.; Wiederstein J.; Pfaff D.; Fleming T.; Miller A.K.; Nawroth P.; Teleman A.A.; Elevated levels of the reactive metabolite methylglyoxal recapitulate progression of type 2 diabetes. Cell Metab 2018,27(4),926-934.e8","journal-title":"Cell Metab"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmet.2018.08.014","volume":"28","author":"Chaudhuri J.","year":"2018","unstructured":"Chaudhuri J.; Bains Y.; Guha S.; Kahn A.; Hall D.; Bose N.; Gugliucci A.; Kapahi P.; The role of advanced glycation end products in aging and metabolic diseases: Bridging Association and Causality. Cell Metab 2018,28(3),337-352","journal-title":"Cell Metab"},{"year":"2012","author":"Khan M.W.A.","key":"ref=100","unstructured":"Khan M.W.A.; Banga K.; Khan W.A.; Gluco-oxidation of proteins in etiology of diabetic retinopathy Diabetic Retinopathy, Mohammad Shamsul Ola, (Ed); InTech,. 2012"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1755-3768.2008.01300.x","volume":"87","author":"Fosmark D.S.","year":"2009","unstructured":"Fosmark D.S.; Berg J.P.; Jensen A.B.; Sandvik L.; Agardh E.; Agardh C.D.; Hanssen K.F.; Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazolone. Acta Ophthalmol 2009,87(5),498-500","journal-title":"Acta Ophthalmol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1053\/meta.2003.50035","volume":"52","author":"Kilhovd B.K.","year":"2003","unstructured":"Kilhovd B.K.; Giardino I.; Torjesen P.A.; Birkeland K.I.; Berg T.J.; Thornalley P.J.; Brownlee M.; Hanssen K.F.; Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes. Metabolism 2003,52(2),163-167","journal-title":"Metabolism"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1113\/expphysiol.2010.053561","volume":"95","author":"Bento C.F.","year":"2010","unstructured":"Bento C.F.; Fernandes R.; Matafome P.; Sena C.; Sei\u00e7a R.; Pereira P.; Methylglyoxal-induced imbalance in the ratio of vascular endothelial growth factor to angiopoietin 2 secreted by retinal pigment epithelial cells leads to endothelial dysfunction. Exp Physiol 2010,95(9),955-970","journal-title":"Exp Physiol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.phymed.2015.12.013","volume":"23","author":"Sampath C.","year":"2016","unstructured":"Sampath C.; Zhu Y.; Sang S.; Ahmedna M.; Bioactive compounds isolated from apple, tea, and ginger protect against dicarbonyl induced stress in cultured human retinal epithelial cells. Phytomedicine 2016,23(2),200-213","journal-title":"Phytomedicine"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00125-011-2393-0","volume":"55","author":"Berner A.K.","year":"2012","unstructured":"Berner A.K.; Brouwers O.; Pringle R.; Klaassen I.; Colhoun L.; McVicar C.; Brockbank S.; Curry J.W.; Miyata T.; Brownlee M.; Schlingemann R.O.; Schalkwijk C.; Stitt A.W.; Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology. Diabetologia 2012,55(3),845-854","journal-title":"Diabetologia"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3132\/dvdr.2004.004","volume":"1","author":"Gale C.P.","year":"2004","unstructured":"Gale C.P.; Futers T.S.; Summers L.K.M.; Common polymorphisms in the glyoxalase-1 gene and their association with pro-thrombotic factors. Diab Vasc Dis Res 2004,1(1),34-39","journal-title":"Diab Vasc Dis Res"},{"key":"ref=107","first-page":"e343","volume":"34","author":"Wu J.C.","year":"2011","unstructured":"Wu J.C.; Li X.H.; Peng Y.D.; Wang J.B.; Tang J.F.; Wang Y.F.; Association of two glyoxalase I gene polymorphisms with nephropathy and retinopathy in Type 2 diabetes. J Endocrinol Invest 2011,34(10),e343-e348","journal-title":"J Endocrinol Invest"}],"container-title":["Current Protein &amp; Peptide Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/175550","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/175550\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/175550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T09:53:47Z","timestamp":1629107627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/175550\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":107,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,12,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389203720666191010155145","relation":{},"ISSN":["1389-2037"],"issn-type":[{"type":"print","value":"1389-2037"}],"subject":[],"published":{"date-parts":[[2020,12,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}